Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Mifepristone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,601Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Optime Care Terminates Distributor Agreement for Korlym
    Optime Care Terminates Distributor Agreement for Korlym

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3164304/0/en/Optime-Care-Terminates-Distributor-Agreement-for-Korlym-mifepristone.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share
    FDA Approves Another Generic Version of Abortion Pill
    FDA Approves Another Generic Version of Abortion Pill

    03 Oct 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-generic-version-abortion-drug-2025-10-02/

    REUTERS
    03 Oct 2025
    Share Share
    FDA Takes Close Look at Mifepristone REMS Program
    FDA Takes Close Look at Mifepristone REMS Program

    25 Sep 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fda-takes-close-look-mifepristone-rems-program-after-request-republican-ags

    FIERCE PHARMA
    25 Sep 2025
    Share Share
    Corcept Faces Teva Lawsuit Over Mifepristone 'Monopoly'
    Corcept Faces Teva Lawsuit Over Mifepristone 'Monopoly'

    15 Sep 2025

    // REUTERS

    https://www.reuters.com/legal/litigation/drugmaker-corcept-must-face-teva-lawsuit-over-mifepristone-monopoly-rare-2025-09-15/

    REUTERS
    15 Sep 2025
    Share Share
    Biotech Leaders, Investors urge FDA to Preserve Access
    Biotech Leaders, Investors urge FDA to Preserve Access

    03 Jul 2025

    // BIOSPACE

    https://www.biospace.com/policy/biotech-leaders-investors-ask-fda-to-maintain-access-to-mifepristone

    BIOSPACE
    03 Jul 2025
    Share Share
    Biotech Leaders Urge FDA to Not Restrict Abortion Pill Access
    Biotech Leaders Urge FDA to Not Restrict Abortion Pill Access

    02 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/more-50-biotech-leaders-urge-fda-not-restrict-mifepristone-access

    FIERCE BIOTECH
    02 Jul 2025
    Share Share